Robert O. McKie
Chief Financial Officer (CFO)
Robert Mckie has over 31 years of successes in various roles in the diagnostic blood products industry, ranging from sales to CEO of several companies. Notably, he served as a Director of Sales at Boston BioMedica, Inc. from 1992-1994. In 1994, he co-founded BioClinical Partners, Inc. and served as Chief Operating Officer until 1999 when the business was acquired by IMPATH Inc. He continued as VP of Operations for IMPATH Predictive Oncology™ division helping develop the GeneBank™ initiative and the IMPATH Clinical Trials Network™ (ICTN).
At Medical Research Networx, Bob has provided consultation services for hospitals and life science companies. He also successfully developed clinical services worldwide, providing protocol-directed and IEC-approved clinical studies that continue to deliver thousands of biospecimens to oncology and infectious disease researchers annually.
Bob holds a BS in Business and currently serves as our CFO.
Peter Miller M.D.
Chief Executive Officer (CEO) / Medical Director
Dr. Miller, a native of the Baltimore / Washington D.C. area started his training as a cadet at the Virginia Military Institute (VMI) where he served in the 3rd highest cadet rank position during the successful integration of women into the cadet corps. There, he completed a BS in Chemistry graduating with distinction as a member of Phi Eta Sigma and Phi Kappa Phi honor societies among other academic honors. He went on to medical school at Sackler, Tel Aviv University in Israel, and finished rotating his intern year at Hadassah Hospital / Hebrew University in Jerusalem. Dr. Miller completed his residency in Clinical Pathology at The George Washington University and a clinical Fellowship in Transfusion Medicine at Johns Hopkins Hospital. He previously served as a medical director at Life South Community Blood Center in Gainesville, Florida before joining our team as CEO and Medical Director at ITM. Dr. Miller has over 13 peer-reviewed journal articles and published abstracts (3 first author articles), 1 patent pending medical device, and has lectured dozens of times to medical facilities and colleagues in the blood industry. He aims to provide an improved donor experience, as well as a unique blend of medical director and laboratory support to customers. He has a particular interest in special antigen units, genotyping of units, and the advantages these units provide to patients. He is also focused on stem cell collections and therapeutic apheresis having completed over 3,000 procedures on pediatric and adult patients. A member of AABB, he serves on the Patient Blood Management Committee Subsection and Cellular Therapies Standards Committee.
Juan H. Kouri, MHSA
Chief Operating Officer (COO)
Director of Marketing
Director of Mobile Operations
Director of Quality & Strategic Development
Director of Hospital Services
Dror Lewy, JD, MBA
Quality Assurance Director
Dror Lewy is a multi-faceted attorney, consultant, and administrator with a history of successfully delivering innovative legal and business solutions based on sound and resourceful strategies. He is currently the Quality Assurance Director for ITM where he is in charge of regulatory and operational compliance.
Mr. Lewy wholeheartedly believes that the key to success is found in creating the right attitude followed by the right action. His personal motto is, “It’s All in the Prep!”, and he tries to implement this philosophy into his professional and personal life as much as possible.
Mr. Lewy has held several legal positions with non-profit, federal, and state governments, as well as in private practice, where he has actively counseled key stakeholders as outside general counsel and compliance consultant for various small businesses.
He graduated from the University of Nebraska at Omaha with a Bachelor’s Degree in Political Science and a Minor in Spanish Language. He holds a Juris Doctor from the University of Nebraska College of Law. He also garnered a Master of Business Administration from the University of Phoenix-San Antonio with a particular interest in operations management.